Charles Dadswell took the reins as interim CEO of Illumina, Inc. in June 2023 after the departure of Francis deSouza. Before stepping into this role, he was already a key player at Illumina as the Senior Vice President and General...
Charles Dadswell took the reins as interim CEO of Illumina, Inc. in June 2023 after the departure of Francis deSouza. Before stepping into this role, he was already a key player at Illumina as the Senior Vice President and General Counsel since 2013. With a law degree from the University of California, Berkeley, his background brings a unique perspective to the biotech field. Dadswell's leadership comes at a critical time for the company, which specializes in genetic sequencing technologies. He was instrumental during the transition period until Jacob Thaysen was appointed as the new CEO in September 2023. His role in managing a top-tier biotechnology company not only illustrates his expertise but also his ability to navigate complex corporate structures and legal landscapes. Under his interim leadership, Illumina aimed to maintain stability while transitioning to a new permanent leader. This brief period of service reflects the urgency and strategic importance of leadership in high-stakes industries like biotech.